More about Balaji Amines Limited
Fundamentals for Balaji Amines Limited
Regulatory Filings for Balaji Amines Limited
Why Oman Is Now India's Most Strategic Trade Partner
Infrastructure Bet Fuels Cement Surge
Apollo FY26: When Healthcare Becomes a Flywheel
NITI Blueprint Could Turn Brain Drain Into $135Bn Engine
Fundamentals for Balaji Amines Limited
Business Operations:
Sector: Basic MaterialsIndustry: Specialty Chemicals
Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethylcarbonate, propylene glycol, and propylene carbonate. The company also provides derivatives comprising di-methyl acetamide, di-methyl amine hydrochloride, tri-methyl amine hydrochloride, di-ethyl amine hydrochloride, tri-ethyl amine hydrochloride, di-methyl urea, choline chloride, mono-ethyl amine hydrochloride, and benzyl tri ethyl ammonium chloride; and pharma excipients, such as poly vinyl pyrrolidone. In addition, it operates Balaji Sarovar Premiere, a hotel in Solapur, Maharashtra, as well as engages in the provision of hotel, restaurant, and hospitality services. The company serves pharmaceutical, agrochemical, paint and resin, animal feed, oil and gas, rubber cleaning chemical, dye and textile, pesticides and insecticides, water treatment chemical, optical brighteners, corrosion inhabitations, cosmetics, explosives, and foundry chemicals industries. It also exports its products to the United States, the United Kingdom, Argentina, Latin America, Canada, Israel, Australia, Bangladesh, Germany, Italy, Egypt, South Africa, and internationally. Balaji Amines Limited was incorporated in 1988 and is headquartered in Solapur, India.
Revenue projections:
With BALAMINES's revenue forecasted to drop below last year's level, investors are expected to take a cautious stance. Such declines typically affect a company's bottom line, reducing profitability and making investors hesitant to invest heavily in the company until financial performance improves.
Financial Ratios:
| currentRatio | 2.340000 |
|---|---|
| forwardPE | 31.699686 |
| debtToEquity | 6.194000 |
| earningsGrowth | 0.617000 |
| revenueGrowth | 0.119000 |
| grossMargins | 0.441400 |
| operatingMargins | 0.203400 |
| trailingEps | 51.680000 |
| forwardEps | 63.600000 |
BALAMINES's current ratio being 2.34 suggests the company will have no issues paying off its short-term debt. With sufficient cash reserves and current assets, BALAMINES can easily cover its immediate liabilities, reflecting solid financial health.
Balaji Amines Limited's positive earnings and revenue growth indicate that the company is well-positioned for business expansion. This growth suggests a strong financial trajectory, with Balaji Amines Limited expected to continue increasing its profits and revenue in the coming periods.
With positive gross and operating margins, BALAMINES's profitability is evident. These metrics suggest the company is efficiently managing its expenses while maintaining strong revenue, highlighting a solid financial foundation.
BALAMINES's forward EPS surpassing its trailing EPS signals projected growth in profitability, with the company expected to perform better this year. This forecast suggests that BALAMINES's earnings will improve compared to the previous financial year, highlighting optimism in its financial outlook.
Price projections:
The price of Balaji Amines Limited has surpassed the higher end of projections, showing strong upward momentum. However, with limited space for further increases, the stock may be due for a correction or stabilization in the near term.
Recommendation changes over time:
BALAMINES has received a favorable buy bias from analysts recently, positioning it as a solid investment opportunity. This sentiment may attract more investors, who view BALAMINES as a stable option to park their money and potentially benefit from the company's continued growth and profitability.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
RAINMUMBAI Turns Rain Into a Financial Asset
India’s IT Sector Faces a Historic Breaking Point
How Independent Directors Failed Rs 2,500 Crore in Value